KIF2C and Familial prostate cancer: To determine the effects of knocking down MCAK in HSPC and CRPC, we used two distinct sets of small interfering RNA (siRNA) specific for MCAK to silence its expression in hormone-sensitive LNCaP and castration-resistant chemotherapy-naïve C4-2B prostate cancer cell lines.